Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Serum homocysteine in rel… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Serum homocysteine in relation to mortality and morbidity from coronary heart disease - a 24 year follow-up of the Population Study of Women in Gothenburg

Artikel i vetenskaplig tidskrift
Författare Dimitri Zylberstein
Calle Bengtsson
Cecilia Björkelund
Sverre Landaas
Valter Sundh
Dag Thelle
Lauren Lissner
Publicerad i Circulation
Volym 109 (5)
Nummer/häfte Feb 10
Sidor 601-606
Publiceringsår 2004
Publicerad vid Hjärt-kärlinstitutionen
Institutionen för samhällsmedicin, Avdelningen för allmänmedicin
Sidor 601-606
Språk en
Länkar circ.ahajournals.org/cgi/content/fu...
Ämnesord homocysteine • women • myocardial infarction
Ämneskategorier Folkhälsomedicinska forskningsområden

Sammanfattning

Department of Primary Health Care, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. dimitri.zylberstein@allmed.gu.se BACKGROUND: Elevated serum total homocysteine (tHcy) is an established risk factor for cardiovascular disease (CVD), especially in men. However, there are few prospective population studies on female cohorts, and none of these has been longer than 13 years. METHODS AND RESULTS: The Population Study of Women in Gothenburg began in 1968/1969, at which time a representative population-based cohort of women aged 38, 46, 50, 54, and 60 years was recruited. The present cohort is a prospective follow-up of 1368 women in the original cohort for whom blood samples were stored and who were free of previous acute myocardial infarction (AMI) at the 1968/1969 baseline. Homocysteine was analyzed in 2001 with frozen serum from the baseline study and related to AMI incidence and mortality during 24 years of follow-up. Cox regression analyses were used with adjustment for age, traditional risk factors, and tHcy modifiers. For the fifth tHcy quintile, relative risk was 1.86 (95% CI 1.06 to 3.26) for AMI and 5.14 (95% CI 2.22 to 11.92) for death due to AMI. Age-standardized Kaplan-Meier plots for the fifth tHcy quintile versus others showed significant differences both for AMI and for death due to AMI that were apparent after 15 years of follow-up. CONCLUSIONS: Homocysteine in middle-aged women is an independent risk factor for myocardial infarction and in particular mortality due to myocardial infarction. The study illustrates that long-term prospective studies might be necessary to show effects of homocysteine levels on AMI morbidity and mortality in women. PMID: 14769681 [PubMed - indexed for MEDLINE]

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?